Tadokoro S, Kuribara H
Division for Behavior Analysis, Gunma University School of Medicine, Maebashi, Japan.
Nihon Yakurigaku Zasshi. 1990 May;95(5):229-38. doi: 10.1254/fpj.95.5_229.
It has been well-known that a chronic abuse of amphetamines induces schizophrenia-like psychotic symptoms, namely amphetamine psychosis. When amphetamines are repeatedly administered to rodents, a reverse tolerance (behavioral sensitization) to the ambulation-increasing and/or stereotypy-producing effect is observed. The process of the reverse tolerance is affected by various factors. A clear reverse tolerance is produced when optimal doses of the drug (2 mg/kg, s.c. for mice, and 0.5-1 mg/kg, s.c., for rats) is administered at intervals of longer than 1 day rather than a shorter interval. Furthermore, the animal has to be put into a freely mobile situation during the presence of the acute drug effect. A cross reverse tolerance is observed between certain types of drugs that show an ambulation-increasing effect, although the potencies are different among the drugs. A reverse tolerance to the stereotypy (in particular sniffing and head-bobbing)-producing effect is also observed when comparatively higher doses of methamphetamine are repeatedly administered. The process is qualitatively identical with the reverse tolerance to the ambulation-increasing effect produced by the repeated administration of comparatively smaller doses. The reverse-tolerance, once established, to both ambulation-increasing and stereotypy-producing effects is almost irreversible even with various treatments such as repeated post-treatment with antipsychotics. The characteristics of reverse tolerance to methamphetamine in animals might be closely correlated to the amphetamine psychosis in humans. It is also necessary to search for a method that effectively reduces the established reverse tolerance to amphetamines.
众所周知,长期滥用苯丙胺会诱发精神分裂症样的精神病症状,即苯丙胺精神病。当向啮齿动物反复给药苯丙胺时,会观察到对增加活动和/或产生刻板行为效应的反向耐受(行为敏化)。反向耐受的过程受多种因素影响。当以大于1天的间隔而非较短间隔给予最佳剂量的药物(小鼠皮下注射2mg/kg,大鼠皮下注射0.5 - 1mg/kg)时,会产生明显的反向耐受。此外,在急性药物效应出现期间,动物必须处于自由活动的状态。在某些显示增加活动效应的药物之间观察到交叉反向耐受,尽管不同药物的效力有所不同。当反复给予相对较高剂量的甲基苯丙胺时,也会观察到对产生刻板行为(特别是嗅探和点头)效应的反向耐受。该过程在质量上与反复给予相对较小剂量所产生的对增加活动效应的反向耐受相同。一旦建立,对增加活动和产生刻板行为效应的反向耐受几乎是不可逆的,即使采用各种治疗方法,如反复给予抗精神病药物进行后续治疗。动物对甲基苯丙胺的反向耐受特征可能与人类的苯丙胺精神病密切相关。还需要寻找一种有效降低已建立的对苯丙胺反向耐受的方法。